In the FTSE Frontier mid-cap segment 31 of the 50 excluded firms were Bangladeshi ones. Of them, Advent Pharma, Acme Laboratories and Singer Bangladesh lost the eligibility to remain in the mid-cap ...
Some results have been hidden because they may be inaccessible to you